Vimarsana
Biggest News Aggregation in the World

Bluestar Genomics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bluestar Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bluestar Genomics Today - Breaking & Trending Today

Global Pancreatic Cancer Diagnostic Market Set to Reach USD 3.90 Billion by 2030 with a CAGR of 6.53% - Vimarsana News

Global Pancreatic Cancer Diagnostic Market Set to Reach USD 3.90 Billion by 2030 with a CAGR of 6.53%

/PRNewswire/ -- The "Pancreatic Cancer Diagnostic Market Size, Share & Trends Analysis Report By Product, By Test Type (Imaging Test, Biopsy, Blood Test,...

AI Detects Hidden, Potentially Curable Pancreatic Cancers - Vimarsana News

AI Detects Hidden, Potentially Curable Pancreatic Cancers

An artificial intelligence model shows potential for detecting early-stage pancreatic cancer on scans of asymptomatic individuals at a stage when surgical cure is possible.

DelveInsight Business Research, LLP: Propulsion of Pancreatic Cancer Pipeline as Novel and Extensive 170+ Therapies Likely to Enter in the Treatment Domain - Vimarsana News

DelveInsight Business Research, LLP: Propulsion of Pancreatic Cancer Pipeline as Novel and Extensive 170+ Therapies Likely to Enter in the Treatment Domain

The prevalence of pancreatic cancer has been rising since the past few years, which prompts the growing demand for treatment options. The increasing prevalence of cancer, the robust pipeline

The Methylation Analysis Landscape In 2022 - Vimarsana News

The Methylation Analysis Landscape In 2022

Within liquid biopsy, methylation has become a key area of interest due to its role in altering gene expression and its ability to provide...

Surveillance program for high risk patients aids in early detection of pancreatic cancer - Vimarsana News

Surveillance program for high risk patients aids in early detection of pancreatic cancer

Surveillance programs for people at high risk of developing pancreatic cancers can help detect precancerous conditions and cancers early, when they are most treatable, according to a new multicenter study directed by experts at the Johns Hopkins Kimmel Cancer Center.